Boehringer Settlement Jumps The Queue For Biosimilar Adalimumab

 
• By David Wallace
  
Balloons
Boehringer Ingelheim has landed in third place with its entry date of 1 July 2023 • Source: Shutterstock

More from Biosimilars

More from Products